Clinical Trials Logo

Filter by:
NCT ID: NCT01308164 Completed - Type 1 Diabetes Clinical Trials

MD Logic Pump Advisor -Pediatric Study

Start date: March 2011
Phase: N/A
Study type: Interventional

The objective of this feasibility study is to evaluate the efficacy and safety of automated determined Insulin pump settings (i.e., basal plan, correction factor, carbohydrate ration and insulin activity time) using the MD-Logic Pump Advisor in individuals with type 1 diabetes. Study design: Prospective study with two segments: (i) Pilot study, 30 days trial evaluating the MD-Logic pump advisor and (ii), randomized controlled trial (RCT), 30-78 days trial comparing MD-Logic pump advisor to the standard of care of patients with type 1 diabetes. The RCT will be initiated after the pilot segment (including data analysis). The pilot segment will include 15-30 pediatric patients. In the RCT, up to 105 (50 minors under this protocol and 55 adults under a separate protocol)eligible subjects will be enrolled to allow for 92 valuable subjects at the end of the study. The subject population will be randomly assigned 1:1 to either the intervention group or control group. At this pediatric sub study approximately 50 patients will participate and at the separate Adults study additional 55 adult patients will participate.

NCT ID: NCT01307553 Recruiting - Clinical trials for Diseased Saphenous Vein Grafts

Over and Under/Aneugraft Pericardium Covered Stent Long Term Follow up Registry

Sleeve III
Start date: September 2010
Phase: N/A
Study type: Observational

The purpose of this study is to track the clinical safety and effectiveness of the Pericardium Covered Stent in "real world" use.

NCT ID: NCT01307527 Enrolling by invitation - Clinical trials for Ehlers-Danlos Syndrome Type 6

Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI

Start date: n/a
Phase: N/A
Study type: Interventional

Brittle Cornea Syndrome and Ehlers-Danlos Syndrome (EDS) type VI are rare collagen-connective tissue disorders that predispose affected individuals to the development of perforated corneas from the mildest of eye trauma or even spontaneously. Clinical studies evaluating riboflavin-corneal crosslinking have found that it dramatically increases corneal rigidity. Given the success and safety of riboflavin crosslinking, the investigators believe that it can increase the corneal stability in patients affected these disseases, preventing perforation. It is furthermore possible, that riboflavin crosslinking will allow corneal transplants to successfully be performed on blind eyes that have already perforated and opacified. The purpose of the study is to determine whether corneal crosslinking can be safely performed on individuals with Brittle Cornea Syndrome or Ehlers-Danlos Syndrome type VI.

NCT ID: NCT01307514 Not yet recruiting - DIABETES Clinical Trials

Effects of Heating Massaging Vibrating Vicinity of the Insulin Delivery Site

Start date: November 2008
Phase: N/A
Study type: Observational

The aim of this experiment is to test the pharmacodynamics and pharmacokinetics of insulin analogs and their dependence on external and physiological alterations. The investigators plan compare the pharmacodynamics of insulin analog delivery in regular conditions and in the presence of increased perfusion of the delivery site, achieved by way of local warming, movement and topical application of Capsaicin cream. The investigators will also test the effect of local heating and topical application of Capsaicin cream on the post prandial glucose levels following a bolus.

NCT ID: NCT01307436 Completed - Hepatitis A Clinical Trials

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

Start date: March 14, 2007
Phase: Phase 3
Study type: Interventional

The primary purpose of this study was to assess whether the protection afforded by Epaxal vaccine co-administered with diphtheria, tetanus, Bordetella pertussis, Haemophilus influenzae type b, and inactivated polio vaccine(DTPaHibIPV), oral polio vaccine (OPV) and (measles mumps and rubella) MMR vaccines against hepatitis A was not inferior to the protection afforded by Epaxal administered alone. The aim of the follow-up phase is to obtain information on the long term protection afforded by Epaxal, and to compare this with an alternative hepatitis A vaccine (Havrix).

NCT ID: NCT01307397 Completed - Malignant Melanoma Clinical Trials

A Study of Vemurafenib in Participants With Metastatic Melanoma

Start date: March 1, 2011
Phase: Phase 3
Study type: Interventional

This multi-center study evaluates the safety and efficacy of vemurafenib in participants with BRAF V600 mutation-positive, surgically incurable, and unresectable Stage IIIC or IV (American Joint Committee on Cancer [AJCC]) metastatic melanoma.

NCT ID: NCT01307254 Recruiting - Clinical trials for NAFLD - Non Alcoholic Fatty Liver Disease

Association Between Non-alcoholic Fatty Liver Disease and Iron Status

BAFLA
Start date: January 2011
Phase: N/A
Study type: Observational

The investigators hypothesize that low iron storages protects from and down-grades non-alcoholic fatty liver disease. The aim of the study is to show the association between the severity of Non-alcoholic fatty liver disease to low iron status.

NCT ID: NCT01307163 Not yet recruiting - Liver Transplant Clinical Trials

Systemic Variables in the Saliva of Children Undergoing Liver Transplantation

Start date: January 2008
Phase: N/A
Study type: Observational

Saliva is used nowadays as a significant diagnostic tool due to the latest technological developments. The research compares two experimental groups; children after liver transplantation and a control group. Our objective is to identify from all the parameters that are evaluated, the ones that differ between the two groups. If such parameters will be found and differ statistically, it will be possible to create a non invasive medical examination protocol, which will probably be much more complaint, and being so would help locate individuals in risk groups with the tendency to develop an end-organ liver disease.

NCT ID: NCT01307150 Not yet recruiting - Atopic Dermatitis Clinical Trials

Climatotherapy At The Dead Sea For Atopic Dermatitis

Start date: June 2009
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the improvement in severity of Atopic Dermatitis and quality of life after 4 weeks of treatment in the Dead Sea.

NCT ID: NCT01306448 Completed - Constipation Clinical Trials

Safety Evaluation of the Vibrating Capsule

Vibrant
Start date: March 2011
Phase: N/A
Study type: Interventional

The study will assess the safety of the vibrating capsule in healthy volunteers first and than for constipation relief constipated individuals.